Database auditsare conducted to ensureongoing data accuracy, completeness, and compliancethroughout the lifecycle of a clinical trial. According to theGood Clinical Data Management Practices (GCDMP, Chapter: Data Quality Assurance and Control), quality audits are most effective when performedperiodically during study conduct, rather than waiting until study completion.

Performing audits periodically allows early detection of data entry errors, protocol deviations, and system inconsistencies, thereby reducing the risk of large-scale data issues before database lock. This proactive approach aligns withrisk-based quality management principlesoutlined inICH E6(R2)and ensures corrective actions are implemented in real time.

Options A and B represent reactive quality control, which occurs too late to prevent data issues. Option C (after first few cases) provides initial validation but does not ensure continuous oversight.

Therefore,option D — “Periodically throughout the study”— represents the optimal and compliant timing for quality audits of the database.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Data Quality Assurance and Control, Section 5.3 – Ongoing Quality Control and Auditing

ICH E6(R2) GCP, Section 5.1.1 – Quality Management System and Risk-Based Monitoring

FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6.5 – Data Review and Auditing Practices